{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:00:37Z","timestamp":1788901237209,"version":"build-2803163510"},"reference-count":220,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":1036,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.nrl.2011.09.012","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T10:49:51Z","timestamp":1323514191000},"page":"102-122","source":"Crossref","is-referenced-by-count":93,"title":["Gu\u00eda para el tratamiento del infarto cerebral agudo"],"prefix":"10.1016","volume":"29","author":[{"given":"M.","family":"Alonso de Leci\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rib\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"D\u00e1valos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Masjuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Caniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mart\u00ednez Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"D\u00edez Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fuentes (Secretar\u00eda)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"\u00c1lvarez-Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Arenillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"D\u00edaz-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Freijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"G\u00e1llego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gil-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Irimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mart\u00ed-F\u00e1bregas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mart\u00ednez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nombela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Purroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rodr\u00edguez-Ya\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Roquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Serena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Simal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vivancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2011.09.012_bib0005","series-title":"Gu\u00eda para el Diagn\u00f3stico y Tratamiento del Ictus. Gu\u00edas Oficiales de la Sociedad Espa\u00f1ola de Neurolog\u00eda N.\u00b0 3","article-title":"Gu\u00eda para el tratamiento del infarto cerebral agudo","author":"Egido","year":"2006"},{"key":"10.1016\/j.nrl.2011.09.012_bib0010","unstructured":"Centre for Evidence Based Medicine [consultado 2011]. Disponible en: http:\/\/www.cebm.net\/"},{"key":"10.1016\/j.nrl.2011.09.012_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2796.1996.39861000.x","article-title":"Stroke management in Europe","volume":"240","author":"Aboderin","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000097646","article-title":"Helsingborg Declaration 2006 on European stroke strategies","volume":"23","author":"Kjellstr\u00f6m","year":"2007","journal-title":"Cerebrovasc Dis"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2011.09.012_bib0025","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1159\/000200452","article-title":"Relevance of stroke code, stroke unit and stroke networks in organization of acute stroke care. The Madrid Acute Stroke Care Program","volume":"27","author":"Alonso de Leci\u00f1ana","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000082786","article-title":"Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain","volume":"19","author":"Belvis","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0025-7753(03)73600-8","article-title":"Impacto del c\u00f3digo ictus en la eficacia del tratamiento trombol\u00edtico","volume":"120","author":"\u00c1lvarez-Sab\u00edn","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.nrl.2011.09.012_bib0040","first-page":"349","article-title":"Influence of the experience and of out-of-hospital stroke code in thrombolytic treatment of acute stroke","volume":"23","author":"Zarza","year":"2008","journal-title":"Neurologia"},{"key":"10.1016\/j.nrl.2011.09.012_bib0045","doi-asserted-by":"crossref","unstructured":"Acker JE, Pancioli AM, Crocco TJ, Eckstein MK, Jauch EC, Larrabee H, et al., American Heart Association, American Stroke Association Expert Panel on Emergency Medical Services Systems, Stroke Council. Implementation strategies for emer- gency medical services within stroke systems of care: a policy statement from the American Heart Association\/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. Stroke. 2007;38:3097\u2014115.","DOI":"10.1161\/STROKEAHA.107.186094"},{"key":"10.1016\/j.nrl.2011.09.012_bib0050","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0055","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.STR.26.12.2233","article-title":"Delay in neurological attention and stroke outcome","volume":"26","author":"D\u00e1valos","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/01.WNL.0000082724.77447.3A","article-title":"VA Stroke Study: neurologist care is associated with increased testing but improved outcomes","volume":"61","author":"Goldstein","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0065","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/STROKEAHA.109.192360","article-title":"Interdisciplinary Council on Peripheral Vascular Disease. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association\/American Stroke Association","volume":"40","author":"Schwamm","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0070","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.44.8.1531","article-title":"Review criteria for hospital utilization for patients with cerebrovascular disease","volume":"44","author":"Lanska","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0075","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.STR.22.8.1026","article-title":"Benefit of a Stroke Unit: a randomized controlled trial","volume":"22","author":"Indredavik","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0080","unstructured":"Stroke Unit Trialists\u2019 Collaboration Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2002;1:CD000197."},{"key":"10.1016\/j.nrl.2011.09.012_bib0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0140-6736(93)92813-9","article-title":"Do stroke units save lives?","volume":"342","author":"Lanhorne","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0090","first-page":"381","article-title":"Experiencia de una Unidad de Ictus en el Hospital Cl\u00ednico de Madrid","volume":"23","author":"Egido","year":"1995","journal-title":"Rev Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2011.09.012_bib0095","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1159\/000049123","article-title":"Acute care in stroke: do stroke units make the difference?","volume":"11","author":"D\u00edez-Tejedor","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0100","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/STROKEAHA.106.478842","article-title":"Does the prevention of complications explain the survival benefit of organized inpatient (stroke unit) care? Further analysis of a systematic review","volume":"38","author":"Govan","year":"2007","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1016\/j.nrl.2011.09.012_bib0105","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1159\/000089366","article-title":"Homeostasis as basis of acute stroke treatment: stroke units are the key","volume":"20","author":"D\u00edez-Tejedor","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0110","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/STROKEAHA.106.480871","article-title":"Stroke units in their natural habitat: systematic review of observational studies","volume":"38","author":"Seenan","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1747-4949.2009.00244.x","article-title":"Stroke Units. Many questions, some answers","volume":"4","author":"Fuentes","year":"2009","journal-title":"International Journal of Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0120","first-page":"717","article-title":"Plan de atenci\u00f3n sanitaria al ictus","volume":"21","author":"\u00c1lvarez Sab\u00edn","year":"2006","journal-title":"Neurolog\u00eda"},{"key":"10.1016\/j.nrl.2011.09.012_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.nrl.2010.05.008","article-title":"Plan de asistencia sanitaria al ictus II 2010","volume":"26","author":"Masjuan","year":"2011","journal-title":"Neurologia"},{"key":"10.1016\/j.nrl.2011.09.012_bib0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000090528","article-title":"Hypoxaemia in acute stroke is frequent and worsens outcome","volume":"21","author":"Rowat","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.02.008","article-title":"A randomized controlled trial of the effect of fixed-dose routine nocturnal oxygen supplementation on oxygen saturation in patients with acute stroke","volume":"19","author":"Roffe","year":"2010","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0140","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1212\/01.WNL.0000092498.75010.57","article-title":"Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset","volume":"61","author":"Oliveira-Filho","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0145","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/HYPERTENSIONAHA.109.133546","article-title":"Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: the TICA study","volume":"54","author":"Leira","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.nrl.2011.09.012_bib0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2796.2003.01291.x","article-title":"U-shaped relationship between mortality and admission blood pressure in patients with acute stroke","volume":"255","author":"Vemmos","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0160","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00004872-200304000-00003","article-title":"International Society of Hypertension: statement on the management of blood pressure in acute stroke","volume":"21","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.nrl.2011.09.012_bib0165","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"Acute Candesartan Cilexitil Therapy in Stroke Survivors Study Group. The ACCESS Study: evaluation of Acute Candesartan Cilexitil Therapy in Stroke Survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0170","doi-asserted-by":"crossref","unstructured":"Blood pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke. The Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD000039. DOI: 10.1002\/14651858.CD000039.","DOI":"10.1002\/14651858.CD000039"},{"key":"10.1016\/j.nrl.2011.09.012_bib0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1474-4422(08)70263-1","article-title":"Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial","volume":"8","author":"Potter","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0180","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(10)70163-0","article-title":"Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial","volume":"9","author":"Robinson","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0185","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000108454","article-title":"Mortality and morbidity of acute cerebral infarction related with temperature and basal analytic parameters","volume":"4","author":"Castillo","year":"1994","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0195","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.STR.31.2.410","article-title":"Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients","volume":"31","author":"Hajat","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1474-4422(09)70051-1","article-title":"The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial","volume":"8","author":"Den Hertog","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0205","first-page":"CD001247","article-title":"Cooling therapy for acute stroke","volume":"21","author":"Den Hertog","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1747-4949.2010.00520.x","article-title":"Hypothermia for Stroke: call to action 2010","volume":"5","author":"Macleod","year":"2010","journal-title":"Int J Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0215","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/jcbfm.2010.44","article-title":"Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?","volume":"30","author":"van der Worp","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nrl.2011.09.012_bib0220","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/hs1001.096194","article-title":"Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview","volume":"32","author":"Capes","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0225","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1161\/01.STR.0000085087.41330.FF","article-title":"Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome","volume":"34","author":"Baird","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0230","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/STROKEAHA.108.519926","article-title":"Spanish Society of Neurology. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study","volume":"40","author":"Fuentes","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0235","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1161\/STROKEAHA.110.591529","article-title":"Persistent hyperglycemia >155mg\/dL in acute ischemic stroke patients: how well are we correcting it?: implications for outcome","volume":"41","author":"Fuentes","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0240","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/01.STR.0000068406.30514.31","article-title":"Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients","volume":"34","author":"\u00c1lvarez-Sab\u00edn","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0245","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/01.STR.0000173161.05453.90.9f","article-title":"Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients","volume":"36","author":"Ribo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1474-4422(07)70080-7","article-title":"Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK)","volume":"6","author":"Gray","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0255","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/STROKEAHA.107.493544","article-title":"Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial","volume":"39","author":"Bruno","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0260","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/01.STR.27.6.1028","article-title":"Effect of malnutrition after acute stroke on clinical outcome","volume":"27","author":"Davalos","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0265","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.STR.0000074037.49197.8C","article-title":"Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial","volume":"34","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0270","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0140-6736(05)70999-5","article-title":"Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial","volume":"365","author":"Dennis","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0275","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1161\/01.STR.28.8.1550","article-title":"Effects of intensity of rehabilitation after stroke. A research synthesis","volume":"28","author":"Kwakkel","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/pri.6120010204","article-title":"Physiotherapy after stroke: more is better?","volume":"1","author":"Langhorne","year":"1996","journal-title":"Physiother Res Int"},{"key":"10.1016\/j.nrl.2011.09.012_bib0285","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/01.STR.32.1.268","article-title":"Does the organization of postacute stroke care really matter?","volume":"32","author":"Langhorne","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0290","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archneur.55.4.454","article-title":"Potential effects of common drugs on stroke recovery","volume":"55","author":"Goldstein","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0295","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(10)70314-8","article-title":"Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial","volume":"10","author":"Chollet","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1545968307312173","article-title":"Citalopram improves dexterity in chronic stroke patients","volume":"22","author":"Zittel","year":"2008","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.nrl.2011.09.012_bib0305","first-page":"CD003437","article-title":"Interventions for treating depression after stroke","volume":"4","author":"Hackett","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0310","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000015830","article-title":"Complications of acute ischaemic stroke","volume":"8","author":"van der Worp","year":"1998","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0315","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archneur.1996.00550040037012","article-title":"Malignant middle cerebral artery territory infarction: clinical course and prognostic signs","volume":"53","author":"Hacke","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0320","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s001340050625","article-title":"Mortality of space-occupying (malignant) middle cerebral artery infarction under conservative intensive care","volume":"24","author":"Berrouschot","year":"1998","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0325","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/hs0202.102376","article-title":"Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke","volume":"33","author":"Schwarz","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0330","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.STR.4.4.547","article-title":"Dexamethasone as treatment in cerebrovascular disease. A controlled study of acute cerebral infarction","volume":"4","author":"Bauer","year":"1973","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/bmj.292.6512.21","article-title":"High dose steroid treatment in cerebral infarction","volume":"292","author":"Norris","year":"1986","journal-title":"Br Med J"},{"key":"10.1016\/j.nrl.2011.09.012_bib0340","first-page":"CD000064","article-title":"Corticosteroids for acute ischaemic stroke","volume":"2","author":"Qizilbash","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0345","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1161\/01.STR.31.11.2719","article-title":"Cochrane report: a systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage","volume":"31","author":"Bereczki","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0350","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.STR.0000078658.52316.E8","article-title":"Mannitol use in acute stroke: case fatality at 30 days and 1 year","volume":"34","author":"Bereczki","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0355","first-page":"CD000096","article-title":"Glycerol for acute stroke","volume":"2","author":"Righetti","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0360","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/STROKEAHA.107.485649","article-title":"Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial","volume":"38","author":"J\u00fcttler","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0365","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/STROKEAHA.107.485235","article-title":"Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial)","volume":"38","author":"Vahedi","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0370","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1474-4422(07)70036-4","article-title":"Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials","volume":"6","author":"Vahedi","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0375","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1474-4422(09)70047-X","article-title":"Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial","volume":"8","author":"Hofmeijer","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0380","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/STROKEAHA.110.605642","article-title":"Hemicraniectomy in malignant middle cerebral artery infarction","volume":"42","author":"Staykov","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0385","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.47.2.393","article-title":"The value of intracranial pressure monitoring in acute hemispheric stroke","volume":"47","author":"Schwab","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0390","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archneur.62.4.537","article-title":"Management of acute cerebellar stroke","volume":"62","author":"Jensen","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0395","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archneur.57.11.1617","article-title":"Seizures after stroke: a prospective multicenter study","volume":"57","author":"Bladin","year":"2000","journal-title":"Arch Neurol"},{"issue":"Suppl 4","key":"10.1016\/j.nrl.2011.09.012_bib0400","first-page":"S83","article-title":"Optimizing therapy of seizures in stroke patients","volume":"67","author":"Ryvlin","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0405","first-page":"CD005398","article-title":"Antiepileptic drugs for the primary and secondary prevention of seizures after stroke","volume":"1","author":"Kwan","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0410","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yebeh.2008.04.025","article-title":"Levetiracetam monotherapy for late poststroke seizures in the elderly","volume":"13","author":"Kutlu","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.nrl.2011.09.012_bib0415","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.braindev.2010.06.008","article-title":"Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy","volume":"33","author":"Belcastro","year":"2011","journal-title":"Brain Dev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1468-1331.2003.00749.x","article-title":"Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial","volume":"11","author":"Aslanyan","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0425","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/01.STR.31.7.1770","article-title":"Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials","volume":"3","author":"Bath","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0430","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0435","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"CAST: randomized placebo controlled trial of early aspirin use in 20000 patients witn acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0440","first-page":"CD001922","article-title":"Physical methods for preventing deep vein thrombosis in stroke","volume":"8","author":"Naccarato","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0445","first-page":"644","article-title":"Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics","volume":"10","author":"Candelario-Jalil","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2011.09.012_bib0450","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1159\/000107393","article-title":"Neuroplasticity and cellular therapy in cerebral infarction","volume":"24","author":"Rodr\u00edguez-Gonz\u00e1lez","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cne.22038","article-title":"Stem cells for ischemic brain injury: a critical review","volume":"515","author":"Burns","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0460","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/hs1001.097093","article-title":"Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial","volume":"32","author":"Saxena","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0465","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.STR.14.5.668","article-title":"Immediate anticoagulation and embolic stroke. A randomized trial","volume":"14","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0470","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.STR.15.5.779","article-title":"Immediate anticoagulation and embolic stroke. Brain Hemorrhage and management options","volume":"15","year":"1984","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0475","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2796.2000.00727.x","article-title":"Effectiveness of heparin treatment for progressing ischaemic stroke: before and after study","volume":"248","author":"R\u00f6d\u00e9n-J\u00fcllig","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0480","first-page":"CD000024","article-title":"Anticoagulants for acute ischaemic stroke","volume":"4","author":"Sandercock","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0485","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","article-title":"Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials","volume":"38","author":"Paciaroni","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0490","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM199512143332402","article-title":"Low molecular weight heparin for the treatment of acute ischemic stroke","volume":"333","author":"Kay","year":"1995","journal-title":"N Eng J Med"},{"issue":"Suppl 4","key":"10.1016\/j.nrl.2011.09.012_bib0495","first-page":"S1","article-title":"Fraxiparine in Ischemic Stroke Study (FISS bis)","volume":"8","author":"Hommel","year":"1998","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0500","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.279.16.1265","article-title":"Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial","volume":"279","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2011.09.012_bib0505","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(00)02085-7","article-title":"Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial","volume":"355","author":"Berge","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0510","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(01)05837-8","article-title":"Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial","volume":"358","author":"Bath","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0515","first-page":"CD000119","article-title":"Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke","volume":"2","author":"Sandercock","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0520","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.283.18.2395","article-title":"The STAT Study: a randomized controlled trial","volume":"283","author":"Sherman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2011.09.012_bib0525","first-page":"1926","article-title":"Outcomes of ancrod in acute ischemic stroke. Independent Data and Safety Monitoring Board for ESTAT. Steering Committee for ESTAT. European Stroke Treatment with Ancrod Trial","volume":"284","author":"Orgogozo","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2011.09.012_bib0530","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","article-title":"Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial","volume":"31","author":"Zheng","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0535","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1553-2712.2003.tb00016.x","article-title":"Treatment of acute stroke with recombinant tissue plasminogen activator and abciximab","volume":"10","author":"Morris","year":"2003","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0540","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.STR.0000117094.41638.EE","article-title":"Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion","volume":"35","author":"Straub","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0545","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.STR.0000157668.39374.56","article-title":"Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial","volume":"36","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0550","unstructured":"The Internet stroke center. Stroke trials [consultado 2011]. Disponible en: http:\/\/www.strokecenter.org\/trials"},{"key":"10.1016\/j.nrl.2011.09.012_bib0555","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The Eurpean Cooperative Acute Stroke Study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2011.09.012_bib0560","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0565","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double\u2013blind placebo\u2013controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0570","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"for bthe ATLANTIS study investigators. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5hours after symptom onset. The ATLANTIS study: a randomized controlled trial","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2011.09.012_bib0575","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"ECASS Investigators. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.nrl.2011.09.012_bib0580","first-page":"S3","article-title":"Thrombolysis in acute ischemic stroke: controlled trials and clinical experience","volume":"53","author":"Hacke","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0585","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","article-title":"Association of outcome with early stroke treatment: pooled analisis of ATLANTIS, ECASS and NINDS rt-PA stroke trials","volume":"363","author":"Hacke","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0590","first-page":"DC:000213","article-title":"Thrombolysis for acute ischemic stroke","volume":"4","author":"Wardlaw","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0595","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0600","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(10)70165-4","article-title":"SITS investigators Implementation and outcome of thrombolysis with alteplase 3-4.5h after an acute stroke: an updated analysis from SITS_ISTR","volume":"9","author":"Ahmed","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0605","doi-asserted-by":"crossref","first-page":"c6046","DOI":"10.1136\/bmj.c6046","article-title":"Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive","volume":"341","author":"Mishra","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.nrl.2011.09.012_bib0610","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2337\/dc10-1125","article-title":"Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA)","volume":"33","author":"Mishra","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nrl.2011.09.012_bib0615","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000063724","article-title":"Seizure at stroke onset: should it be an absolute contraindication to thrombolysis?","volume":"14","author":"Selim","year":"2002","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0620","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/STROKEAHA.106.480566","article-title":"Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations","volume":"38","author":"De Keyser","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0625","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.59.6.862","article-title":"Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator","volume":"59","author":"Alexandrov","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0630","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1056\/NEJMoa041175","article-title":"Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke","volume":"351","author":"Alexandrov","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0635","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.21723","article-title":"Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial","volume":"66","author":"Molina","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0640","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0404.2009.01241.x","article-title":"Combined thrombolysis with abciximab and rtPA in patients with middle cerebral artery occlusion","volume":"121","author":"Gahn","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrl.2011.09.012_bib0645","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/STROKEAHA.109.572040","article-title":"Phase IIB\/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial","volume":"41","author":"Haley","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0650","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1212\/01.wnl.0000344168.05315.9d","article-title":"Levi CRAcute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window","volume":"72","author":"Parsons","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0655","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0660","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.STR.0000217403.66996.6d","article-title":"Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9hours after stroke onset","volume":"37","author":"Furlan","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0665","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(08)70267-9","article-title":"Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study","volume":"8","author":"Hacke","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0670","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"(PROACT): a phase II randomized trial of recombinant prourokinase by direct arterial delivery in acute middle cerebral artery stroke","volume":"29","author":"Del Zoppo","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0675","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2011.09.012_bib0680","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/STROKEAHA.107.492348","article-title":"Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign","volume":"39","author":"Mattle","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0685","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/STROKEAHA.109.574335","article-title":"Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0690","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/CIRCULATIONAHA.109.192217","article-title":"American Heart Association. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association","volume":"119","author":"Meyers","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.nrl.2011.09.012_bib0695","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.292.15.1862","article-title":"Long-term outcome after intravenous thrombolysis of basilar artery occlusion","volume":"292","author":"Lindsberg","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.nrl.2011.09.012_bib0700","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/hs0102.101900","article-title":"Acute intravenous-intra-arterial revascularization therapy for severe ischemic stroke","volume":"33","author":"Hill","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0705","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/01.STR.0000020363.23725.67","article-title":"Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion","volume":"33","author":"Zaidat","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0710","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.STR.0000121641.77121.98","article-title":"Combined intravenous and intraarterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study","volume":"35","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0715","unstructured":"IMS III. Interventional Management of Stroke III. Disponible en: http:\/\/www.strokecenter.org\/trials\/trialDetail.aspx?tid=747&search_string=IMS, 2011."},{"key":"10.1016\/j.nrl.2011.09.012_bib0720","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.STR.0000147718.12954.60","article-title":"MERCI 1: a phase 1 study of mechanical embolus removal in cerebral sschemia","volume":"35","author":"Gobin","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0725","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.107.497115","article-title":"Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial","volume":"39","author":"Smith","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0730","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12028-008-9167-7","article-title":"Comparison of mechanical embolectomy and intraarterial thrombolysis in acute ischemic stroke within the MCA: MERCI and Multi MERCI compared to PROACT II","volume":"10","author":"Josephson","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.nrl.2011.09.012_bib0735","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/STROKEAHA.108.544957","article-title":"The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease","volume":"40","year":"2009","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2011.09.012_bib0740","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1159\/000200457","article-title":"Cerebral protection, brain repair and cell therapy in sschemic stroke","volume":"27","author":"Guti\u00e9rrez","year":"2009","journal-title":"Cerebrovascular Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0745","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuropharm.2007.12.007","article-title":"Neuroprotection for ischemic stroke: Past, present and future","volume":"55","author":"Ginsberg","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0750","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","article-title":"Update of the stroke therapy academic industry roundtable preclinical recommendations","volume":"40","author":"Fisher","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0755","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000108482","article-title":"Meta-analysis of oral nimodipine trials in acute ischemic stroke","volume":"4","author":"Mohr","year":"1994","journal-title":"Cerebrovasc Dis"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2011.09.012_bib0760","first-page":"S127","article-title":"VENUS-Very Early Nimodipine Use in Stroke: final results from a randomised placebo controlled trial","volume":"9","author":"Horn","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0765","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000108483","article-title":"Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischemic stroke","volume":"4","author":"Wahlgren","year":"1994","journal-title":"Cerevrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0770","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.STR.22.4.437","article-title":"Early treatment of ischemic stroke with a calcium antagonist","volume":"33","author":"Rosenbaum","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0775","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.20.5.604","article-title":"A double blind randomized trial of PY 108-086 in acute ischemic cerebral infarction","volume":"20","author":"Oczkowski","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0780","unstructured":"Lataste X, Maurer W, Whitehead J and the ASCLEPIOS study group. Application of sequential methods to clinical trial in stroke. The Asclepios Study. 2nd World Congress of Stroke, 1992. S 16."},{"key":"10.1016\/j.nrl.2011.09.012_bib0785","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0404.1996.tb00171.x","article-title":"Fllunarizine in nstroke treatment (FIST): a double blind placebo controlled trial in Scandinavia and the Netherlands","volume":"93","author":"Franke","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrl.2011.09.012_bib0790","series-title":"The cochrane Library, Issue 3","article-title":"Calcium antagonists for acute ischemic stroke (cochrane Review)","author":"Horn","year":"2000"},{"issue":"Suppl 4","key":"10.1016\/j.nrl.2011.09.012_bib0795","first-page":"S127","article-title":"USA. POST-011: efficacy and safety of maxipost in patients with acute stroke","volume":"11","author":"Bozik","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0800","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0140-6736(05)62166-6","article-title":"Termination of acute stroke studies involving selfotel treatment (letter)","volume":"349","author":"Davis","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0805","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/01.STR.26.2.254","article-title":"Safety, tolerability and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke","volume":"26","author":"Albers","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0810","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.286.21.2673","article-title":"Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial","volume":"286","author":"Albers","year":"2001","journal-title":"J AM Med Assoc"},{"key":"10.1016\/j.nrl.2011.09.012_bib0815","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(04)15490-1","article-title":"Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomized controlled trial","volume":"363","author":"Muir","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0820","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(00)02326-6","article-title":"Glycine antagonist (gavastinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial","volume":"355","author":"Lees","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0825","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.285.13.1719","article-title":"Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial","volume":"285","author":"Sacco","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.nrl.2011.09.012_bib0830","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/01.STR.28.12.2338","article-title":"Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group","volume":"28","author":"Grotta","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0835","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000015847","article-title":"Multinational randomized controlled trial of lubeluzole in acute ischemic stroke. European and Australian Lubeluzole Ischemic Stroke Study Group","volume":"8","author":"Diener","year":"1998","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0840","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.STR.30.1.21","article-title":"Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients","volume":"30","author":"Wahlgren","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0845","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/hs0102.101478","article-title":"CLASS-I\/H\/T Investigators. Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results","volume":"33","author":"Lyden","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0850","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1212\/WNL.57.7.1199","article-title":"The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results","volume":"57","author":"Lyden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0855","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000090210","article-title":"Diazepam to improve acute stroke outcome: results of the early GABA-Ergic activation study in stroke trial. A randomized double-blind placebo-controlled trial","volume":"21","author":"Lodder","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0860","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/01.STR.31.6.1234","article-title":"Cervene (Nalmefene) in acute ischemic stroke: final results of a phase III efficacy study. The Cervene Stroke Study Investigators","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0865","first-page":"195","article-title":"Safety and efficacy of 6mg\/kg\/day tirilazad mesylate in patients with acute ischemic stroke (TESS study)","volume":"27","author":"Peters","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0870","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.STR.27.9.1453","article-title":"A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS)","volume":"27","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0875","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/str.29.6.1256\/a","article-title":"High dose tirilazad mesylate in patients with acute stroke (RANTTAS II)","volume":"29","author":"Haley","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0880","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1161\/01.STR.31.9.2257","article-title":"Tirilazad Mesylate in acute ischemic stroke: a systematic review","volume":"31","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0885","doi-asserted-by":"crossref","unstructured":"Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H, para el Ebselen Study Group. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Stroke. 1998;29:12\u201317.","DOI":"10.1161\/01.STR.29.1.12"},{"key":"10.1016\/j.nrl.2011.09.012_bib0890","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","article-title":"Effect of a novel free radical scavenger, edaravone (MCI-186) on acute brain infarction. Randomized placebo-controlled double-blind study at multicenters","volume":"15","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0895","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa052980","article-title":"Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for acute ischemic stroke","volume":"354","author":"Lees","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0900","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMoa070240","article-title":"NXY-059 for the treatment of acute ischemic stroke","volume":"357","author":"Shuaib","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrl.2011.09.012_bib0905","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1212\/WNL.57.8.1428","article-title":"Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial","volume":"57","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0910","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.STR.0000092527.33910.89","article-title":"Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke","volume":"34","author":"Krams","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0915","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/01616412.1995.11740327","article-title":"Citicoline (CDP-Choline): mechanisms of action and effects on ischemic brain injury","volume":"17","author":"D\u2019Orlando","year":"1995","journal-title":"Neurol Res"},{"key":"10.1016\/j.nrl.2011.09.012_bib0920","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.49.3.671","article-title":"A randomized dose-response trial of citicoline in acute ischemic stroke patients","volume":"49","author":"Clark","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0925","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/01.STR.30.12.2592","article-title":"A randomized efficacy trial of citicoline in patients with acute ischemic stroke","volume":"30","author":"Clark","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0930","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/WNL.57.9.1595","article-title":"A phase III randomized efficacy trial of 2000mg citicoline in acute ischemic stroke patients","volume":"57","author":"Clark","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib0935","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/1531-8249(200011)48:5<713::AID-ANA4>3.0.CO;2-#","article-title":"Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators","volume":"48","author":"Warach","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib0940","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.STR.0000038691.03334.71","article-title":"Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials","volume":"33","author":"D\u00e1valos","year":"2002","journal-title":"Stroke"},{"issue":"Suppl","key":"10.1016\/j.nrl.2011.09.012_bib0945","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1161\/STROKEAHA.110.605568","article-title":"Citicoline preclinical and clinical update 2009-2010","volume":"42","author":"D\u00e1valos","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0950","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.STR.28.12.2347","article-title":"Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group","volume":"28","author":"De Deyn","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0955","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000065683","article-title":"European-Australian Fiblast (Trafermin) in Acute Stroke Group. Fiblast (trafermin) in acute stroke: results of the European-Australian phase II\/III safety and efficacy trial","volume":"14","author":"Bogousslavsky","year":"2002","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib0960","first-page":"CD000094","article-title":"Gangliosides for acute ischemic stroke","author":"Candelise","year":"2001","journal-title":"Cochrane Database Sys Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0965","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1747-4949.2009.00340.x","article-title":"A double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of Cerebrolysin in patients with acute ischaemic stroke in Asia-CASTA","volume":"4","author":"Hong","year":"2009","journal-title":"Int J Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0970","first-page":"297","article-title":"Cerebrolysin adjuvant treatment in Broca\u2018s aphasics following first acute ischemic stroke of the left middle cerebral artery","volume":"3","author":"Jianu","year":"2010","journal-title":"J Med Life"},{"key":"10.1016\/j.nrl.2011.09.012_bib0975","first-page":"CD007026","article-title":"Cerebrolysin for acute ischaemic stroke","volume":"4","author":"Ziganshina","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib0980","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/01.STR.18.4.691","article-title":"Multicenter Trial of hemodilution in acute ischemic stroke. I. Results in the total patient population","volume":"18","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0985","first-page":"318","article-title":"Haemodilution in acute stroke: results of the Italian haemodilution trial","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib0990","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.STR.23.2.181","article-title":"Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke","volume":"23","author":"Goslinga","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib0995","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.STR.0000231389.34701.b5","article-title":"The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke II: neurologic outcome and efficacy analysis","volume":"37","author":"Palesch","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib1000","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1042\/BST0341323","article-title":"The ALIAS (ALbumin In Acute Stroke) phase III randomized multicentre clinical trial: design and progress report","volume":"34","author":"Ginsberg","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.nrl.2011.09.012_bib1005","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","article-title":"Minocycline treatment in acute stroke: an open-label, evaluator-blinded study","volume":"69","author":"Lampl","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib1010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/01.STR.0000125863.93921.3f","article-title":"Favorable outcome of ischemic stroke in patients pretreated with statins","volume":"35","author":"Mart\u00ed-F\u00e0bregas","year":"2004","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2011.09.012_bib1015","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1159\/000200450","article-title":"Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome","volume":"27","author":"Fuentes","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib1020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1468-1331.2008.02370.x","article-title":"The beneficial effect of statins treatment by stroke subtype","volume":"16","author":"Mart\u00ednez-S\u00e1nchez","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib1025","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1212\/01.wnl.0000269789.09277.47","article-title":"Statin treatment withdrawal in ischemic stroke: a controlled randomized study","volume":"69","author":"Blanco","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2011.09.012_bib1030","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/STROKEAHA.110.605923","article-title":"Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis","volume":"42","author":"Biffi","year":"2011","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2011.09.012_bib1035","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1159\/000200457","article-title":"Cerebral protection, brain repair, plasticity and cell therapy in ischemic stroke","volume":"27","author":"Guti\u00e9rrez","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib1040","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"Ehrenreich","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib1045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neuroscience.2010.11.054","article-title":"Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats","volume":"175","author":"Guti\u00e9rrez-Fern\u00e1ndez","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nrl.2011.09.012_bib1050","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.nrl.2011.09.012_bib1055","first-page":"151","article-title":"Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study","volume":"27","author":"Su\u00e1rez-Monteagudo","year":"2009","journal-title":"Restor Neurol Neurosci"},{"key":"10.1016\/j.nrl.2011.09.012_bib1060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.nrl.2010.09.013","article-title":"Cerebral venous thrombosis: a diagnostic and treatment update","volume":"26","author":"Guenther","year":"2011","journal-title":"Neurologia"},{"key":"10.1016\/j.nrl.2011.09.012_bib1065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(07)70029-7","article-title":"Cerebral venous thrombosis: an update","volume":"56","author":"Bousser","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2011.09.012_bib1070","doi-asserted-by":"crossref","unstructured":"Saposnik G, Barinagarrementeria F, Brown Jr RD, Bushnell CD, Cucchiara B, Cushman M, et al, on behalf of the American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42:1158-92.","DOI":"10.1161\/STR.0b013e31820a8364"},{"key":"10.1016\/j.nrl.2011.09.012_bib1075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0140-6736(91)90607-Q","article-title":"Heparin treatment in sinus venous treatment thrombosis","volume":"338","author":"Einh\u00e4upl","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.nrl.2011.09.012_bib1080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.STR.30.3.484","article-title":"Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis","volume":"30","author":"De Bruijn","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib1085","first-page":"CD002005","article-title":"Anticoagulation for cerebral sinus thrombosis","volume":"4","author":"Stam","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nrl.2011.09.012_bib1090","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/STROKEAHA.110.588822","article-title":"Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis","volume":"41","author":"Coutinho","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.nrl.2011.09.012_bib1095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000068833","article-title":"Thrombolytics for cerebral sinus thrombosis: a systematic review","volume":"15","author":"Canh\u00e3o","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.nrl.2011.09.012_bib1100","doi-asserted-by":"crossref","unstructured":"Ferro JM, Crassard I, Coutinho JM, Canh\u00e3o P, Barinagarrementeria F, Cucchiara B, et al, and the Second International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT 2) Investigators. Decompressive surgery in cerebrovenous thrombosis. A multicentre registry and a systematic review of individual patient data. Stroke. 2011;42:2825-31.","DOI":"10.1161\/STROKEAHA.111.615393"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485311004063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485311004063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T18:42:41Z","timestamp":1561056161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485311004063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":220,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0213485311004063"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2011.09.012","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}